4.4 Article

COVID-19 severity from Omicron and Delta SARS-CoV-2 variants

期刊

INFLUENZA AND OTHER RESPIRATORY VIRUSES
卷 16, 期 5, 页码 832-836

出版社

WILEY
DOI: 10.1111/irv.12982

关键词

COVID-19; Delta; Omicron; SARS-CoV-2; severity; whole genome sequencing (WGS)

资金

  1. Centers for Disease Control and Prevention (CDC) [75D3012110094]
  2. National Institute of Allergy and Infectious Diseases [R21AI142321-02S1, R21AI142321, R21AI154016, R21AI149262]
  3. National Heart, Lung, and Blood Institute [K23HL148638, R01HL146401]
  4. National Institutes of Health [UL1RR024975, P30CA68485, P30EY08126, G20RR030956]

向作者/读者索取更多资源

The clinical outcomes of infections caused by the Omicron variant were compared to those caused by the Delta variant. It was found that infections caused by the Omicron variant were less severe, with significantly lower morbidity and mortality rates, compared to those caused by the Delta variant.
The Omicron variant of SARS-CoV-2 achieved worldwide dominance in late 2021. Early work suggests that infections caused by the Omicron variant may be less severe than those caused by the Delta variant. We sought to compare clinical outcomes of infections caused by these two strains, confirmed by whole genome sequencing, over a short period of time, from respiratory samples collected from SARS-CoV-2 positive patients at a large medical center. We found that infections caused by the Omicron variant caused significantly less morbidity, including admission to the hospital and requirement for oxygen supplementation, and significantly less mortality than those caused by the Delta variant.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据